Grade Post Therapy Clin (yc) (Corpus Adenosarcoma)
Data Item Details
Parent Schema: Corpus Adenosarcoma
NAACCR Item: #1068
NAACCR XML ID: gradePostTherapyClin
Organization Field Mapping
Organization | Field Name | ID# | ID Name | Required |
|---|---|---|---|---|
KCR | Grade Post Therapy Clin (yc) | 30141 | GradePostTherapyClin | yes |
SEER | Grade Post Therapy Clin (yc) | gradePostTherapyClin | yes |
Valid Values
Notes
Note 1 Leave Grade Post Therapy Clin (yc) blank when
No neoadjuvant therapy
Clinical or pathological case only
Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor
There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological
Note 2 Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy.
Note 3 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.
Note 4 G3 includes anaplastic.
Note 5 Sarcomatous overgrowth (S) takes priority over L and H
Example Pathology report Adenocarcinoma with sarcomatous overgrowth, high and low grade
Code Grade to S for the sarcomatous overgrowth
Note 6 Code 9 (unknown) when
Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented
Microscopic exam is done after neoadjuvant therapy and there is no residual cancer
Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available
Code | Description |
|---|---|
1 | G1: Well differentiated |
2 | G2: Moderately differentiated |
3 | G3: Poorly differentiated or undifferentiated |
L | Low grade |
H | High grade |
S | Sarcomatous overgrowth |
9 | Grade cannot be assessed (GX); Unknown |
<BLANK> | See Note 1 |
For official definitions and additional context, refer to the NAACCR Data Dictionary.